Publication date: Jun 01, 2026
Advanced age is a major determinant of adverse outcomes during acute infections, yet the immunological mechanisms by which aging alters immune regulation and shapes disease trajectories remain poorly understood. Using SARS-CoV-2 infection as a model of acute viral challenge, we investigated how aging alters myeloid responses in the lungs. Across infected mouse models and human cohorts, disease severity was associated with a pronounced shift in myeloid balance, characterized by an increased neutrophil-to-monocyte ratio. Neutrophils exhibited prolonged retention within the pulmonary microvasculature and formed large co-aggregates with monocytes. In parallel, severe disease was associated with a defect in classical monocyte activation in the lungs, notably through reduced PD-L1 upregulation. This defect was not observed in the circulation, indicating tissue-dependent dysregulation of inflammatory and regulatory markers. Aging further accentuated this imbalance. Both aged mice and elderly patients displayed a reduced proportion of PD-L1-expressing lung monocytes, despite enhanced pulmonary neutrophil recruitment. This age-associated alteration distinguished severe from non-severe disease and characterized a maladaptive myeloid response to acute viral challenge. Together, these findings identify impaired, compartment-specific myeloid immune regulation as a central feature of age-related vulnerability to severe infection. They highlight that tissue-dependent regulatory failure compounds inflammatory excess as a key determinant of disease outcome and suggest that restoring myeloid regulatory function may offer therapeutic benefit in older individuals during acute respiratory infections.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | SARS-CoV-2 Infection |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | infections |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | respiratory infections |
| drug | DRUGBANK | Diethylstilbestrol |
| disease | MESH | Des |
| pathway | REACTOME | Hemostasis |
| drug | DRUGBANK | L-Citrulline |
| drug | DRUGBANK | Coenzyme M |
| pathway | REACTOME | Reproduction |
| disease | MESH | inflammation |
| disease | MESH | viral infections |
| disease | MESH | lymphopenia |
| pathway | REACTOME | Innate Immune System |
| disease | MESH | acute respiratory distress syndrome |
| disease | MESH | death |
| disease | MESH | immunothrombosis |
| disease | MESH | strain |
| drug | DRUGBANK | Cefaclor |
| disease | MESH | CCL |
| drug | DRUGBANK | Iron |
| disease | MESH | cross infection |
| drug | DRUGBANK | Xylazine |
| drug | DRUGBANK | Ketamine |
| disease | MESH | PBS |
| disease | MESH | tremors |
| disease | MESH | hypothermia |
| disease | MESH | weight loss |
| disease | MESH | included |
| disease | MESH | hematological malignancies |
| disease | MESH | Disease Models Animal |